scholarly journals Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component

Molecules ◽  
2021 ◽  
Vol 26 (19) ◽  
pp. 5949
Author(s):  
Jingyuan Wu ◽  
Tuoyu Zhou ◽  
Yinxue Wang ◽  
Yanbiao Jiang ◽  
Yiqing Wang

Ovarian cancer ranks seventh in the most common malignant tumors among female disease, which seriously threatens female reproductive health. It is characterized by hidden pathogenesis, missed diagnosis, high reoccurrence rate, and poor prognosis. In clinic, the first-line treatment prioritized debulking surgery with paclitaxel-based chemotherapy. The harsh truth is that female patients are prone to relapse due to the dissemination of tumor cells and drug resistance. In these circumstances, the development of new therapy strategies combined with traditional approaches is conductive to improving the quality of treatment. Among numerous drug resources, botanical compounds have unique advantages due to their potentials in multitarget functions, long application history, and wide availability. Previous studies have revealed the therapeutic effects of bioactive plant components in ovarian cancer. These natural ingredients act as part of the initial treatment or an auxiliary option for maintenance therapy, further reducing the tumor and metastatic burden. In this review, we summarized the functions and mechanisms of natural botanical components applied in human ovarian cancer. We focused on the molecular mechanisms of cell apoptosis, autophagy, RNA and DNA lesion, ROS damage, and the multiple-drug resistance. We aim to provide a theoretical reference for in-depth drug research so as to manage ovarian cancer better in clinic.

2018 ◽  
Vol 427 ◽  
pp. 9-17 ◽  
Author(s):  
Qingyu Luo ◽  
Xiaowei Wu ◽  
Yiping Zhang ◽  
Tong Shu ◽  
Fang Ding ◽  
...  

1995 ◽  
Vol 171 (4) ◽  
pp. 954-960 ◽  
Author(s):  
S. Morris ◽  
G. H. Bai ◽  
P. Suffys ◽  
L. Portillo-Gomez ◽  
M. Fairchok ◽  
...  

1998 ◽  
Vol 70 (2) ◽  
pp. 176-182 ◽  
Author(s):  
Franziska Joncourt ◽  
Katharina Buser ◽  
Hansjörg Altermatt ◽  
Marisa Bacchi ◽  
Aurelia Oberli ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1353
Author(s):  
Wamidh H. Talib ◽  
Ahmad Riyad Alsayed ◽  
Muna Barakat ◽  
May Ibrahim Abu-Taha ◽  
Asma Ismail Mahmod

Cancer is one of the leading causes of death globally. The development of drug resistance is the main contributor to cancer-related mortality. Cancer cells exploit multiple mechanisms to reduce the therapeutic effects of anticancer drugs, thereby causing chemotherapy failure. Natural products are accessible, inexpensive, and less toxic sources of chemotherapeutic agents. Additionally, they have multiple mechanisms of action to inhibit various targets involved in the development of drug resistance. In this review, we have summarized the basic research and clinical applications of natural products as possible inhibitors for drug resistance in cancer. The molecular targets and the mechanisms of action of each natural product are also explained. Diverse drug resistance biomarkers were sensitive to natural products. P-glycoprotein and breast cancer resistance protein can be targeted by a large number of natural products. On the other hand, protein kinase C and topoisomerases were less sensitive to most of the studied natural products. The studies discussed in this review will provide a solid ground for scientists to explore the possible use of natural products in combination anticancer therapies to overcome drug resistance by targeting multiple drug resistance mechanisms.


Sign in / Sign up

Export Citation Format

Share Document